Patient Preferences and Values in Decision Making for Migraines: A Systematic Literature Review

Table 4

Preferences and values for preventive treatment.

Study	Treatment process	Treatment outcome
Cowan et al. [17]	Most patients preferred monthly or quarterly dosing, while a small proportion had no preference
Mansfield et al. [18]	Patients tended to inject monthly or daily rather than twice a month when treating	It was more important to change the number of migraine attack days from a 10% reduction to a 50% reduction than to avoid adverse events
Kol et al. [19]	Fifty-five percent of patients wanted to use prophylaxis; only 8% actually used this treatment
Peres et al. [20]	Therapies with higher response rates, fewer adverse events, and less frequent dosing regimens were preferred	Patients rated efficacy as the most important aspect of preventive treatment outcome
Kelman [21]		A percentage of 95.2 expected a reduction in frequency of headaches from their treatment, 95.6% a reduction in severity of pain, 79.7% to be symptom-free, 27.8% a cure, and 95.5% an improved quality of life
Rozen [22]	If greater efficacy could be achieved, patients did not mind using more than 1 prophylactic agent
Wenzel et al. [23]		The vast majority of patients wanted to use over-the-counter drugs to effectively prevent migraine